info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Press Releases » Global Metabolomics Market will be worth USD 6.68 billion by 2030.

Global Metabolomics Market will be worth USD 6.68 billion by 2030.


Published Date: Apr-2022 | Report Format:Electronic (PDF)

The report Global Metabolomics Market by product and service (Metabolomics Instruments and Bioinformatics Tools and Services), Application (Biomarker discovery, Toxicology Testing, Personalized Medicine, Metabolomics Drug discovery, Nutrigenomics, Functional Genomics), Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Inborn Errors of Metabolism, Metabolic Disorders), End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes )and Regions-Global Forecast to 2030.” The Global Metabolomics Market share was USD 1.9 billion in 2020. It is predicted to reach USD 6.68 billion by 2030, representing a CAGR of 13.4 percent throughout the forecasted period”. 


To know more about the report, Click on the link :- https://www.strategicmarketresearch.com/market-report/metabolomics-market

 

KEY FACTORS AUGMENTING THE MARKET GROWTH

Some of the most notable factors that are majorly driving the overall growth of the market worldwide are an increase in the government and Private investments in the metabolomics market for the research and development. As to The Metabolomics Innovation Centre (TMIC), metabolomics has experienced tremendous growth in the last decade with high-impact discoveries in several diseases, which have increased investments in metabolomics facilities across the globe and accelerated the appearance of more than 80 university-based metabolomics facilities across North America over the past decade.

 

By Product and Service, the “metabolomics instruments” segment held the highest share in 2020

Based on Product and Service, the Metabolomics Market is broadly classified into Metabolomics Instruments: Separation Tools, Detection Tools, and Bioinformatics Tools, and Services, which are Bioinformatics Services Bioinformatics Tools, and Databases. The metabolomics instruments segment dominates the overall market with a steady CAGR during the estimated period with the rapid adoption of metabolomics due to smooth technological operations leading to workflow efficiency, precision, reliability, and processing data.

 

By Application, the “biomarker” segment accounted for the maximum share of the market in 2020

Based on Application, the Metabolomics Market is broadly classified into Biomarker discovery, Toxicology Testing, Personalized Medicine, Metabolomics Drug discovery, Nutrigenomics, and Functional Genomics. The biomarker discovery segment dominated the overall due to increased adoption of metabolic biomarkers and technological advancements. 

 

By Indication, the “Cancer” segment accounted for the maximum share of the market in 2020

Based on Indication, the Metabolomics Market is broadly classified into Cancer, Neurological Disorders, Cardiovascular Diseases, Inborn Errors of Metabolism, and Metabolic Disorders. The cancer segment dominated the overall market share and even had the highest growth in the market, which can be attributed to the increase in the no of cancer cases and the demand for the treatment therapy for cancer.

 

By End-User, the “academic and research institutes” segment held the maximum share of the market in 2020

Based on End User, the Metabolomics Market is broadly classified into Contract Research Organizations, Academic and Research Institutes, and Pharmaceutical and Biotechnology Companies. The academic and research institutes dominated the overall market share due to increasing research activities in metabolomics and the addition of funds to the academic and research institutes for the study.

 

Based on Region, North America held the maximum share of the market with a decent CAGR value throughout the stipulated time frame of 2020-2030 due to significant players operating in the metabolomics market, growing research, and rising preclinical activities of pharma companies. 

 

Key Competitive Players 

The key players included in the Global Metabolomics Market include Waters Corporation, Merck KGaA, GE Healthcare, Hitachi High-Technologies Corporation, Human Metabolome Technologies, Inc., LECO Corporation (US), Metabolon, Inc., Bio-Rad Laboratories, Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific, Danaher Corporation, Bruker Corporation, PerkinElmer, Scion Instruments, DANI Instruments S.p.A., GL Sciences, SRI Instruments, Kore Technology Ltd., JASCO, Inc. 

 

 Recent Developments: -

  • In July 2021, Thermo Fisher Scientific and the University of California launched a research collaboration, the centre of excellence in clinical metabolomics, to provide innovations, standard operating procedures, and best practices to the metabolomics community. 
  • In April 2021, BioMerieux received CE Marking for the VITEK MS PRIME, a novel MALDI-TOF mass spectrometry identification system, which is a crucial step in the microbiology workflow.

Choose License Type



$0
$0
$0
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: (+1) 315-636-4233
  • UK: (+44) 1622-370-614
  • IN: (+91) 826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved